Literature DB >> 14267249

STUDIES ON AGRANULOCYTOSIS. VII. LIMITED PROLIFERATIVE POTENTIAL OF CPZ-SENSITIVE PATIENTS.

A V PISCIOTTA.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS; BONE MARROW CELLS; CELL DIVISION; CHLORPROMAZINE; CHLORPROMAZINE TOXICOLOGY; DNA; DRUG TOLERANCE; LEUKOCYTES; METABOLISM; PHARMACOLOGY; THYMIDINE; TOXICOLOGIC REPORT; TRITIUM

Mesh：

Substances：

Year:  1965        PMID： 14267249

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  7 in total

Review 1.  [Drug-induced agranulocytoses].

Authors:  R Gross; K P Hellriegel
Journal:  Blut       Date:  1976-06

Review 2.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 3.  Drug-induced agranulocytosis.

Authors:  V Pisciotta
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

4.  Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.

Authors:  J W Wei; R A Hickie; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 5.  On the possible mechanisms and predictability of clozapine-induced agranulocytosis.

Authors:  A V Pisciotta; S A Konings; L L Ciesemier; C E Cronkite; J A Lieberman
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

6.  Agranulocytosis during treatment with chlozapine.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I P Palva
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

7.  Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Authors:  Pareesa Kamgar-Dayhoff; Tinatin I Brelidze
Journal:  Oncotarget       Date:  2021-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.